Development of a Healthcare Service Platform for Successful Aging

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorSunmi Song

About this trial

The goal of this living-lab clinical trial is to test the effectiveness of digital health monitoring and feedback platform for community dwelling older adults. The main questions it aims to answer are:

* Identify digital sensing variables that are predictive of mental and physical health declines and health emergencies of older adults * Develop digital health monitoring service to inform individualized daily health status of older adults users * Develop ICT network to share the daily health status and emergency signals with community based healthcare service providers and family caregivers if an older adult user approves of them to receive their health information.

Participants will be asked to participate in a living lab using a wearable sensor, motion sensor, and smartphone applications for 6 weeks and also take part in pre-mid-post surveys to evaluate the usability, accuracy, and effectiveness of the digital healthcare service platform to improve health managements and connections with community and family caregivers.

If there is a comparison group: Researchers will compare age and gender matched control group to see if health status of the living-lab group is better than the control group.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Community dwelling older adults who are 65 years old and older

Disqualifiers

Older adults with cognitive, sensory, and functional problems that may hinder them from participating surveys.

Older adults with iOS mobile device that would not allow them to use the developed mobile application.

Older adults in nursing home or who are hospitalized because this platform is designed to support independent living of an older adults in their home.

Trial design

Design model

Sequential

Treatments tested in this trial

  • Living-lab digital intervention group

    Behavioral

    Older adults will receive individualized daily health feedback via the mobile applications, which will be shared with caregivers. They will also receive support for health emergency by the platform sending automatic emergency push alarm to community and family caregivers.

Treatment groups

84 Participants
are divided into 2 treatment groups
Group A: Living-lab digital intervention groupExperimental treatment 1 intervention
Group B: Control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Patient Health Questionnaire-9 (PHQ-9)

PHQ-9 items will be used to assess daily depressive symptoms using a chatbot, the total score ranged from 0 to 27, higher score representing more severe depressive status.

Time frame
Daily assessments across 6 weeks
2

Sleep fragmentation index

Number of awakening divided by total sleep time in percentage, ranged from 0 to 100, higher score indicating more fragmented sleep.

Time frame
Daily assessments across 6 weeks
3

Daily steps

Number of steps per day, which can be ranged from 0 to infinite. Higher numbers of steps indicate more physical activity for the day.

Time frame
Daily assessments across 6 weeks
4

Intensity of physical activity

Minutes of light, moderate, and intense physical activity, which can be ranged from 0 to 1440 minutes. More active minutes at each of the three intensity levels presents more physical activities.

Time frame
Daily assessments across 6 weeks

Secondary outcomes

1

Geriatic depression

Geriatric depression scale score ranges from 0-15 with higher scores indicating more severe depressive symptoms.

Time frame
Before and after the 6 week living lab periods
2

SF-12 Quality of life

Short Form survey-12 (SF-12) measures levels of the health related quality of life, which ranges from 0 to 100 with higher scores presenting better quality of life.

Time frame
Before and after the 6 week living lab periods
3

Pain related functional limitations

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), which ranged from 0 to 90 with higher scores indicating worse pain related functional limitations in one's daily living.

Time frame
Before and after the 6 week living lab periods
4

Chronic pain

Brief Pain Inventory (BPI) score ranges from 1 to 10 with higher score indicating more severe pain.

Time frame
Before and after the 6 week living lab periods

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sunmi Song

Lead sponsor

Korea University

Sponsor institution